![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() |
![]() |
![]() |
![]() |
|
![]() Âàøà êîðçèíà:
Òîâàðîâ:
-- øò.
Íà ñóììó:
0 ðóá.
|
||
![]() |
![]() |
Ïîäåëèòüñÿ:
Ëÿ Ðîø Ïîçå Ýôàêëàð ÄÓÎ ÏËÞÑ Êðåì-ãåëü êîððåêòèðóþùèé äëÿ æèðíîé è ïðîáëåìíîé êîæè ÍÀÁÎÐ (3 øòóêè ïî 40 ìë) La Roche Posay Effaclar DUO [+] (L104520NAB)Öåíà: 3 330
îæèäàåòñÿ
Êîë-âî:
|
Ïîäåëèòüñÿ:
|
|
Ëÿ Ðîø Ïîçå Ýôàêëàð ÄÓÎ ÏËÞÑ Êðåì-ãåëü êîððåêòèðóþùèé äëÿ æèðíîé è ïðîáëåìíîé êîæè ÍÀÁÎÐ (3 øòóêè ïî 40 ìë) La Roche Posay Effaclar DUO [+] (L104520NAB)Öåíà: 3 330
îæèäàåòñÿ
Êîë-âî:
|
Ñîãëàøåíèå îá èñïîëüçîâàíèè èíôîðìàöèè
Äëÿ æèðíîé ïðîáëåìíîé êîæè ñ âûðàæåííûìè èçìåíåíèÿìè: çàêóïîðåííûå ïîðû, ëîêàëüíûå âîñïàëèòåëüíûå èçìåíåíèÿ, êðàñíûå è òåìíûå ñëåäû ïîñòàêíå
EFFACLAR DUO + îáåñïå÷èâàåò êîìïëåêñíîå âîçäåéñòâèå íà æèðíóþ ïðîáëåìíóþ êîæó áëàãîäàðÿ äåéñòâèþ 4-õ àêòèâíûõ êîìïîíåíòîâ íà 2 îñíîâíûõ ïðèçíàêà: ëîêàëüíûå âîñïàëèòåëüíûå ýëåìåíòû: Niacinamide (Íèàöèíàìèä) è Piroctone-Olamine (Ïèðîêòîí-Îëàìèí) ïðåïÿòñòâóþò ïðîöåññó âîñïàëèòåëüíîé òðàíñôîðìàöèè çàêóïîðåííûõ ïîð, òîðìîçÿò ïðîöåññ ðàçìíîæåíèÿ áàêòåðèé. Çàêóïîðåííûå ïîðû: êîìáèíàöèÿ LHA (Ëèïî-Ãèäðîêñè-Êèñëîòû)/Niacinamide (Íèàöèíàìèäà) îáåñïå÷èâàåò ìèêðîýêñôîëèàöèþ êëåòîê êîæè è î÷èùàåò ïîðû. Îáîãàùåííûé Òåðìàëüíîé âîäîé La Roche-Posay, EFFACLAR DUO + îêàçûâàåò óñïîêàèâàþùåå, ñìÿã÷àþùåå äåéñòâèå, óñòðàíÿåò âèäèìûå èçìåíåíèÿ çàêóïîðåííûõ ïîð.
Ñîäåðæèò çàïàòåíòîâàííûé êîìïîíåíò Ïðîêåðàä, êîòîðûé óìåíüøàåò âîñïàëåíèå, à òàêæå ïðåïÿòñòâóåò ïðîÿâëåíèþ ïðîòèâîñïàëèòåëüíîé ãèïåðïèãìåíòàöèè.
Çíà÷èòåëüíî óìåíüøåíû âèäèìûå ïðîÿâëåíèÿ æèðíîé ïðîáëåìíîé êîæè.
×åðåç 24 ÷àñà ïîêðàñíåíèÿ óìåíüøàþòñÿ.
×åðåç 8 äíåé âûðàæåííûå íåñîâåðøåíñòâà çíà÷èòåëüíî ñîêðàùàþòñÿ.
×åðåç 4 íåäåëè -52% âîñïàëèòåëüíûõ ýëåìåíòîâ. Ïîðû î÷èùåíû, êîæà áîëåå ãëàäêàÿ, âûäåëåíèå êîæíîãî ñàëà íîðìàëèçóåòñÿ.
Òþáèê 40 ìë
Íàíîñèòü óòðîì è âå÷åðîì íà î÷èùåííóþ êîæó ëèöà, èçáåãàÿ îáëàñòè âîêðóã ãëàç. Íåêîìåäîãåííî.
Ïðåäñòàâëåííûé ìàòåðèàë íà web-ñàéòå ïðåäíàçíà÷åí äëÿ ýêñïåðòîâ â îáëàñòè çäðàâîîõðàíåíèÿ. Îò 12.04. 2010 ãîäà îò ïîëîæåíèÿ çàêîíà Ðîññèéñêîé Ôåäåðàöèè N 61-ÔÇ "Îá îáðàùåíèè ëåêàðñòâåííûõ ñðåäñòâ" íà ñàéòå ïðåäñòàâëåíû òîëüêî äîñòîâåðíûå òåêñòû ìîíîãðàôèé, ñïðàâî÷íèêè, ïóáëèêàöèè íàó÷íîãî òèïà, äîêëàäû ñ êîíãðåññîâ, íàó÷íûõ êîíôåðåíöèé, ñèìïîçèóìîâ, ñîâåòîâ. Ðàçìåùåíû èíñòðóêöèè ïî èñïîëüçîâàíèþ ëåêàðñòâ, ïðåäíàçíà÷åííûõ äëÿ âðà÷åé, êîòîðûå îïóáëèêîâûâàþòñÿ â òåìàòè÷åñêèõ ïå÷àòíûõ èçäàíèÿõ èëè â ïå÷àòíûõ èíôîðìàöèîííûõ ìàòåðèàëàõ, íàïðàâëåííûõ íà ïðîôåññèîíàëîâ â îòðàñëè îáðàùåíèÿ ëåêàðñòâ.
 óïàêîâêå êàæäîãî ïðåïàðàòà ïðèñóòñòâóåò ëèñòîê-âêëàäûø, èìåííî íà íåì ðàçìåùåíà âñÿ íóæíàÿ èíôîðìàöèÿ ïî èñïîëüçîâàíèþ ëþáîãî ëåêàðñòâà íà òåððèòîðèè ÐÔ.
Ñîãëàñíî çàêîíîäàòåëüíîé áàçå ÐÔ, ýòà èíôîðìàöèÿ ìîæåò çàäåéñòâîâàòüñÿ èñêëþ÷èòåëüíî ýêñïåðòàìè â ñôåðå çäðàâîîõðàíåíèÿ è íå ìîæåò èñïîëüçîâàòüñÿ ïàöèåíòàìè äëÿ ïðèíÿòèÿ ðåøåíèÿ, êàñàþùåãîñÿ óïîòðåáëåíèÿ ëåêàðñòâà.
Òàêîãî ðîäà ñâåäåíèÿ íå ìîãóò èçó÷àòüñÿ â êîíòåêñòå ðåêîìåíäàöèé ïàöèåíòàì ïî äèàãíîñòèêå, ïðîôèëàêòèêå èëè æå ëå÷åíèþ îïðåäåëåííûõ çàáîëåâàíèé. Áîëåå òîãî ìàòåðèàë íå ÿâëÿåòñÿ çàìåíîé ïðÿìîé êîíñóëüòàöèè ñî ñïåöèàëèñòîì â ñâîåé îòðàñëè, òî åñòü âðà÷îì óçêîé ñïåöèàëüíîñòè.
Íåïðàâèëüíî èç äàííîãî ìàòåðèàëà èñòîëêîâûâàòü âñå êàê ïðèçûâ íå ïðîôåññèîíàëîâ ñàìîñòîÿòåëüíî ïîêóïàòü, èëè æå ïðèíèìàòü ïðåäñòàâëåííûå òîâàðû.
Ðàçìåùåííàÿ èíôîðìàöèÿ íå ìîæåò áðàòüñÿ â ðàñ÷åò äëÿ ïðèíÿòèÿ îêîí÷àòåëüíîãî ðåøåíèÿ êàñàþùåãîñÿ èçìåíåíèÿ ïîðÿäêà èëè æå ðåæèìà óïîòðåáëåíèÿ ëåêàðñòâ, ïðîïèñàííûõ âðà÷îì.
![]() |
![]() |
|
![]() Âàøà êîðçèíà:
Òîâàðîâ:
-- øò.
Íà ñóììó:
0 ðóá.
|
||
![]() |
![]() |
![]() |
![]() |
|
Âñå íîâèíêè |
||
![]() |
![]() |
![]() |
Âíèìàíèå... Òîâàð äîáàâëåí â êîðçèíó |